Molecular Testing for NSCLC Biomarkers including EGFR, KRAS, BRAF, ALK, MET exon 14 skipping, ALK, ROS1, RET, NTRK1, NTRK2, NTRK3
Histopathology
Description
Next Generation Sequencing using the Thermofisher Ion Torrent Genexus Sequencer.
Indications
To enable tumour profiling of Non Small Cell Lung Cancer (NSCLC) and the identification of suitable targeted therapies
Sample Type
Embedded paraffin wax tissue blocks, paraffin wax curls (minimum tumour content 20%)
Turnaround Time
Approximately 10 days
Testing Frequency
Twice Weekly (Monday & Wednesday)
Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.
Your contact for this test
Stephanie Hibberd BSc (Hons), MSc, CSci, FIBMS
Laboratory Manager - Histopathology
You are enquiring about
Molecular Testing for NSCLC Biomarkers including EGFR, KRAS, BRAF, ALK, MET exon 14 skipping, ALK, ROS1, RET, NTRK1, NTRK2, NTRK3